ORAMED PHARMACEUTICALS INC. (ORMP)
Pharmaceutical Preparations
Latest Price
$4.07
TTM P/E
1.57
Normalized P/E
5.69
Div Yield
--
Book Value
5.84
P/B Ratio
0.70
Valuation metrics
adjust assumptions →EPS: $1.50
Book value / share: $5.09
Formula: √(22.5 × EPS × BVPS)
Graham Number
$13.10
+222% upside
EPS: $1.50
Target P/E: 6×
Formula: EPS × P/E
P/E Fair Value
$9.00
+121% upside
Institutional Ownership
31.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 3.17M | $10.0M | 7.74% | -- | 2026-03-31 |
| Aquamarine Financial (Cayman) Ltd | 2.11M | $7.0M | 5.16% | +139.3K | 2026-03-31 |
| MERCER GLOBAL ADVISORS INC /ADV | 1.91M | $6.0M | 4.67% | -- | 2026-03-31 |
| Gem Investment Advisors, LLC | 1.64M | $5.0M | 4.01% | -358.7K | 2026-03-31 |
| Murchinson Ltd. | 1.32M | $4.0M | 3.21% | -25.0K | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 600.7K | $2.0M | 1.47% | -11.4K | 2026-03-31 |
| MARSHALL WACE, LLP | 259.6K | -- | 0.63% | +556 | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 158.2K | -- | 0.39% | +7.7K | 2026-03-31 |
| WELLS FARGO & COMPANY/MN | 157.6K | -- | 0.39% | +27.0K | 2026-03-31 |
| RITHOLTZ WEALTH MANAGEMENT | 155.5K | -- | 0.38% | -- | 2026-03-31 |